- Hepatocellular carcinoma in individuals with HBV infection or HBV-HCV co-infection in a low endemic countryLoa Davidsdottir
Department of Gastroenterology and Hepatology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
Scand J Gastroenterol 45:944-52. 2010..The aim of this nationwide cohort study was to assess the risk for hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV) infection or HBV and hepatitis C virus (HCV) co-infection in Sweden, a low endemic country...
- A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosisSoo Aleman
Departments of Gastroenterology and Hepatology and Department of Infectious Diseases, Karolinska University Hospital, at Karolinska Institutet, 171 76 Stockholm, Sweden
Clin Infect Dis 57:230-6. 2013....
- Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?Pia Edenvik
Department of Medicine, Division of Gastroenterology and Hepatology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Liver Int 35:1862-71. 2015..We aimed to determine the use of HCC-surveillance in patients diagnosed with HCC in a European setting, and to identify the reasons for surveillance failures...
- Pegylated interferon and ribavirin combination therapy for chronic hepatitis C virus infection in patients with Child-Pugh Class A liver cirrhosisEliya Syed
Department of Gastroenterology and Hepatology, Karolinska University Hospital, Sweden
Scand J Gastroenterol 43:1378-86. 2008..The aim of this study was to investigate the efficacy and tolerability of combination therapy in unselected patients with Child-Pugh Class A liver cirrhosis at a Swedish university clinic...